Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hearing loss
Pharma
Astellas depreciates FibroGen's Evrenzo, nixes cell therapy deal
Astellas is doing some house cleaning under new CEO Naoki Okamura, booking impairments from three programs before its full-year earnings report.
Angus Liu
Apr 12, 2023 11:02am
Sensorion taps Eveon to deliver gene therapy to inner ear
Jan 31, 2023 10:35am
After 2 CRLs, FDA signs off on Fennec's hearing loss drug
Sep 21, 2022 10:10am
Decibel's hearing loss therapy protects patients in early trial
Jun 28, 2022 9:35am
FDA deals blow to hearing loss treatment for pediatric patients
Nov 29, 2021 11:12am
Decibel nets $127M IPO to trial surgical gene therapy delivery
Feb 15, 2021 8:00pm
